Acute myeloid leukemia other diagnostic studies: Difference between revisions

Jump to navigation Jump to search
No edit summary
Line 15: Line 15:
===PCR===
===PCR===
PCR is a highly sensitive DNA test used to recognize cancer cells in acute myeloid leukemia.
PCR is a highly sensitive DNA test used to recognize cancer cells in acute myeloid leukemia.
===Biopsy===
[[Bone marrow examination]] is often performed to identify the type of abnormal blood cells; however, if there are many leukemic cells circulating in the peripheral blood, a bone marrow [[biopsy]] may not be necessary
Bone marrow is examined via [[light microscopy]] as well as [[flow cytometry]] to diagnose the presence of leukemia, to differentiate acute myeloid leukemia from other types of leukemia (e.g. [[acute lymphoblastic leukemia]]), and to classify the subtype of disease. A sample of marrow or blood is typically also tested for [[chromosomal translocation]]s by routine [[cytogenetics]] or [[fluorescent in situ hybridization]].


==References==
==References==

Revision as of 16:21, 2 September 2015

Acute myeloid leukemia Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Acute myeloid leukemia from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardigram

Chest X Ray

Echocardiograph and Ultrasound

CT

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Acute myeloid leukemia other diagnostic studies On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Acute myeloid leukemia other diagnostic studies

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Acute myeloid leukemia other diagnostic studies

CDC on Acute myeloid leukemia other diagnostic studies

Acute myeloid leukemia other diagnostic studies in the news

Blogs on Acute myeloid leukemia other diagnostic studies

Directions to Hospitals Treating Acute myeloid leukemia

Risk calculators and risk factors for Acute myeloid leukemia other diagnostic studies

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Raviteja Guddeti, M.B.B.S. [2] Carlos A Lopez, M.D. [3]

Overview

Other Diagnostic Studies

Cytochemistry

This is a test used to differentiate acute myeloid leukemia from acute lymphoblastic leukemia. Using a stain which reacts to a particular type of leukemic cells. The stain causes the granules of most acute myeloid leukemia cells to appear as black spots under the microscope, but it does not cause acute lymphoblastic cells to change colors.

Flow cytometry and Immunohistochemistry

In these tests special antibodies are used to detect cancer cells and thus to differentiate acute myeloid leukemia from other leukemias.

PCR

PCR is a highly sensitive DNA test used to recognize cancer cells in acute myeloid leukemia.

Biopsy

Bone marrow examination is often performed to identify the type of abnormal blood cells; however, if there are many leukemic cells circulating in the peripheral blood, a bone marrow biopsy may not be necessary

Bone marrow is examined via light microscopy as well as flow cytometry to diagnose the presence of leukemia, to differentiate acute myeloid leukemia from other types of leukemia (e.g. acute lymphoblastic leukemia), and to classify the subtype of disease. A sample of marrow or blood is typically also tested for chromosomal translocations by routine cytogenetics or fluorescent in situ hybridization.

References

Template:Hematology



Template:WikiDoc Sources